GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gubra AS (CHIX:GUBRAc) » Definitions » Total Long-Term Liabilities

Gubra AS (CHIX:GUBRAC) Total Long-Term Liabilities : kr61.5 Mil (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Gubra AS Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Gubra AS's Total Long-Term Liabilities for the quarter that ended in Dec. 2023 was kr61.5 Mil.


Gubra AS Total Long-Term Liabilities Historical Data

The historical data trend for Gubra AS's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gubra AS Total Long-Term Liabilities Chart

Gubra AS Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Total Long-Term Liabilities
54.16 52.60 46.45 60.96 61.53

Gubra AS Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
Total Long-Term Liabilities Get a 7-Day Free Trial 46.45 - 60.96 67.41 61.53

Gubra AS Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.


Gubra AS Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Gubra AS's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Gubra AS (CHIX:GUBRAC) Business Description

Industry
Traded in Other Exchanges
Address
Hørsholm Kongevej 11B, Hørsholm, DNK, 2970
Gubra AS is a specialized preclinical CRO and biotech company focused on peptide-based drug discovery within metabolic and fibrotic diseases.

Gubra AS (CHIX:GUBRAC) Headlines

No Headlines